| pubmed-article:11455740 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11455740 | lifeskim:mentions | umls-concept:C0175677 | lld:lifeskim |
| pubmed-article:11455740 | lifeskim:mentions | umls-concept:C0036983 | lld:lifeskim |
| pubmed-article:11455740 | lifeskim:mentions | umls-concept:C0073115 | lld:lifeskim |
| pubmed-article:11455740 | lifeskim:mentions | umls-concept:C0311404 | lld:lifeskim |
| pubmed-article:11455740 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:11455740 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11455740 | pubmed:dateCreated | 2001-7-17 | lld:pubmed |
| pubmed-article:11455740 | pubmed:abstractText | Retinols seem to be of clinical importance in ameliorating the clinical consequences of septic shock. These beneficial effects of retinols are suggested to be due to an antioxidant property. The present study was undertaken in order to confirm or rule out such an effect of retinol palmitate (RP) in experimental septic shock by measuring F2-isoprostanes and a major prostaglandin F2 alpha metabolite as indicators of oxidative injury and inflammatory response, respectively. | lld:pubmed |
| pubmed-article:11455740 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11455740 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11455740 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11455740 | pubmed:month | May | lld:pubmed |
| pubmed-article:11455740 | pubmed:issn | 0304-4602 | lld:pubmed |
| pubmed-article:11455740 | pubmed:author | pubmed-author:BasuSS | lld:pubmed |
| pubmed-article:11455740 | pubmed:author | pubmed-author:ErikssonMM | lld:pubmed |
| pubmed-article:11455740 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11455740 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:11455740 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11455740 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11455740 | pubmed:pagination | 265-9 | lld:pubmed |
| pubmed-article:11455740 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:meshHeading | pubmed-meshheading:11455740... | lld:pubmed |
| pubmed-article:11455740 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11455740 | pubmed:articleTitle | Retinol palmitate counteracts oxidative injury during experimental septic shock. | lld:pubmed |
| pubmed-article:11455740 | pubmed:affiliation | Section of Geriatrics, Faculty of Medicine, Uppsala University, Box 609, SE-751 25 Uppsala, Sweden. samar.basu@geriatrik.uu.se | lld:pubmed |
| pubmed-article:11455740 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11455740 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
